Dataset Information

Novel peptides from the edible bivalve Ruditapes decussatus target apoptosis, autophagy, and FGF19-FGFR4 signaling in human cancer cell lines

ABSTRACT: Bioactive peptides have recently emerged as promising candidates for cancer treatment due to their selective cytotoxicity toward cancer cells. The bivalve mollusk Ruditapes decussatus contains bioactive compounds that have not been thoroughly investigated for their potential anticancer properties. In this study, isolation and purification of peptide mixtures from R. decussatus was performed using FPLC chromatography followed by de novo sequence analysis. Using de novo peptide sequencing, a total of 135 peptides (ranging from 2,681.6 to 5,925.12 Da) were identified, of which 57 peptides (42%) were predicted to exhibit anticancer potential upon analysis with AntiCP 2.0, highlighting their possible therapeutic utility. Additionally, fractions were tested against liver (HepG2) and colorectal (HT-29) cancer cell lines, as well as normal human hepatocytes and VERO (obtained from kidney) cells, to evaluate their cytotoxic effects. Fractions 2 and 3 showed significant anticancer activity against both cancer cell lines, while exhibiting minimal cytotoxicity toward normal cells. These fractions induced apoptosis, as evidenced by the downregulation of Bcl-2 and upregulation of caspase-3, and also activated autophagy, marked by increased Beclin-1 expression. Flow cytometry analysis revealed enhanced apoptotic cell death and G1/S phase cell cycle arrest in the treated cancer cells. Morphological analysis further confirmed the presence of apoptotic changes. Overall, the peptides derived from R. decussatus demonstrated the ability to induce apoptosis and cell cycle arrest in cancer cells, with a highly selective effect on colorectal carcinoma, suggesting their potential as anticancer agents for further investigation.

INSTRUMENT(S):

ORGANISM(S): Ruditapes Decussatus

TISSUE(S): Whole Body

SUBMITTER: Ahmed Hussein

LAB HEAD: Ahmed Hussein

PROVIDER: PXD067801 | Pride | 2025-10-06

REPOSITORIES: Pride

ACCESS DATA

Dataset's files

Source:

Items per page:

1 - 5 of 11

Publications

Novel peptides from the edible bivalve Ruditapes decussatus target apoptosis, autophagy, and FGF19-FGFR4 signaling in human cancer cell lines.

Hussein Ahmed A A AAA Salem Maha B MB ElZallat Mohamed M Ghoname Samah I SI Habib Mohamed R MR Hammam Olfat Ali OA El-Dabaa Ehab E Okasha Hend H

Scientific reports 20251001 1

Bioactive peptides have recently emerged as promising candidates for cancer treatment due to their selective cytotoxicity toward cancer cells. The bivalve mollusk Ruditapes decussatus contains bioactive compounds that have not been thoroughly investigated for their potential anticancer properties. In this study, isolation and purification of peptide mixtures from R. decussatus were performed using FPLC chromatography followed by de novo sequence analysis. Using de novo peptide sequencing, a tota ...[more]

PMID: 41034324

Similar Datasets

Project description:P. falciparum blood stage parasites maintain an intricate system of membranes, requiring precise mechanisms of lipid synthesis and trafficking. Lipid transfer proteins (LTPs) at interorganelle membrane contact sites (MCSs) have emerged as key for ensuring proper lipid distribution in cells but so far remain largely unexplored in protozoans. In many cases this involves the ER which is a central hub for lipid synthesis and contacts all other organelles. In this project, we used the ER adaptor VAP, which recruits LTPs in other organisms, to identify essential mechanisms of lipid transfer at ER-MCSs in P. falciparum blood stages. Using proximity biotinylation techniques, combined with LC-MS/MS, proteins in proximity to P. falciparum VAP (PfVAP) were identified. The raw data for these experiments is here deposited. Using microscopy and cell biology techniques the proteins identified as hits through this experiment were filtered to uncover direct interacting partners of PfVAP, of which one was a bridge-like LTP homologous to opisthokont VPS13, hence renamed PfVPS13L1. This protein folds as a ~22nm rod with an internal hydrophobic groove that allows bulk flow of lipids between two adjacent membranes and localizes to hotspots within the inner membrane complex (IMC), a de novo generated organelle required for proper schizogony. While the ER-resident PfVAP binds the N-terminal end of the PfVPS13L1 bridge, we hypothesized its C-terminal end binds early IMC membranes. To confirm this, we performed another proximity biotinylation experiment to label proteins in proximity to the C-terminal end of PfVPS13L1, and identified several known IMC proteins as hits. The raw data for this experiment is deposited here as well. Further studies of parasites with PfVPS13L1 loss of function revealed a defect in IMC membrane extension and parasite segmentation, which in turn led to the complete inhibition of parasite propagation in RBCs. Our data supports a model in which PfVPS13L1 is critical for the formation of invasive stages by mediating bulk flow of lipids from the ER to the growing IMC. This function is homologous to what was previously reported for other VPS13 or VPS13-like opisthokont proteins, where their functions include the expansion of the isolation membrane during autophagosome formation or the expansion of the sporulation membrane during yeast meiosis. Our study thus reveals that bulk transfer of lipids via bridge-like LTPs is a conserved mechanism for membrane expansion throughout eukaryotes, including protozoa.In the files uploaded, the code P3190 corresponds to the DiQ-BioIDof PfVAP (Fig. 2b), and P3872 and P3754 to DiQ-BioID of C-terminal PfVPS13L1 (Fig. 4g and Extended Data Fig. 7c, respectively).

Project description:Alzheimer’s disease (AD) is an unremitting neurodegenerative disorder characterized by cerebral amyloid-β (Aβ) accumulation and gradual decline in cognitive function. Changes in brain energy metabolism arise in the preclinical phase of AD, suggesting an important metabolic component of early AD pathology. Neurons and astrocytes function in close metabolic collaboration, which is essential for the recycling of neurotransmitters in the synapse. However, how this metabolic interplay may be affected during the early stages of AD development has not been sufficiently investigated. Here, we provide an integrative analysis of cellular metabolism during the early stages of Aβ accumulation in the cerebral cortex and hippocampus of the 5xFAD mouse model of AD. Our electrophysiological examination revealed an increase in spontaneous excitatory signaling in hippocampal brain slices of 5xFAD mice. This hyperactive neuronal phenotype coincided with decreased hippocampal TCA cycle metabolism mapped by stable 13C isotope tracing. Particularly, reduced astrocyte TCA cycle activity led to decreased glutamine synthesis, in turn hampering neuronal GABA synthesis in the 5xFAD hippocampus. In contrast, cerebral cortical slices of 5xFAD mice displayed an elevated capacity for oxidative glucose metabolism suggesting a metabolic compensation. When we explored the brain proteome and metabolome of the 5xFAD mice, we found limited changes, supporting that the functional metabolic disturbances between neurons and astrocytes are early events in AD pathology. In addition, we show that synaptic mitochondrial and glycolytic function was impaired selectively in the 5xFAD hippocampus, whereas non-synaptic mitochondrial function was maintained. These findings were supported by ultrastructural analyses demonstrating disruptions in mitochondrial morphology, particularly in the 5xFAD hippocampus. Collectively, our study reveals complex region and cell specific metabolic adaptations, in the early stages of amyloid pathology, which may be fundamental for the progressing synaptic dysfunction in AD.

Project description:Cervical cancer is still the leading cause of cancer mortality worldwide even after introduction of vaccine against Human papillomavirus (HPV), due to low vaccine coverage, especially in the developing world. Cervical cancer is primarily treated by Chemo/Radiotherapy, depending on the disease stage, with Carboplatin/Cisplatin-based drug regime. These drugs being non-specific, target rapidly dividing cells, including normal cells, so safer options are needed for lower off-target toxicity. Natural products offer an attractive option compared to synthetic drugs due to their well-established safety profile and capacity to target multiple oncogenic hallmarks of cancer like inflammation, angiogenesis, etc. In the current study, we investigated the effect of Bergenin (C-glycoside of 4-O-methylgallic acid), a natural polyphenol compound that is isolated from medicinal plants such as Bergenia crassifolia, Caesalpinia digyna, and Flueggea leucopyrus . Bergenin has been shown to have anti-inflammatory, anti-ulcerogenic, and wound healing properties but its anticancer potential has been realized only recently. We performed a proteomic analysis of cervical carcinoma cells treated with bergenin and found it to influence multiple hallmarks of cancers, including apoptosis, angiogenesis, and tumor suppressor proteins. It was also involved in many different cellular processes unrelated to cancer, as shown by our proteomic analysis. Further analysis showed bergenin to be a potent -angiogenic agent by reducing key angiogenic proteins like Galectin 3 and MMP-9 (Matrix Metalloprotease 9) in cervical carcinoma cells. Further understanding of this interaction was carried out using molecular docking analysis, which indicated MMP-9 has more affinity for bergenin as compared to Galectin-3. Cumulatively, our data provide novel insight into the anti-angiogenic mechanism of bergenin in cervical carcinoma cells by modulation of multiple angiogenic proteins like Galectin-3 and MMP-9 which warrant its further development as an anticancer agent in cervical cancer.

			Action	DRS
	2P2.raw	Raw
	2P3.raw	Raw
	evidence2.txt	Txt
	evidence3.txt	Txt
	msms2.txt	Txt